Complete remission of brain metastases of ovarian cancer following high-dose carboplatin: a case report and pharmacokinetic study
- 1 September 1990
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 25 (5) , 382-383
- https://doi.org/10.1007/bf00686244
Abstract
Brain metastases developed in a 40-year-old woman with relapsed ovarian cancer 2 years after cisplatin-based combination chemotherapy. After a single dose of 800 mg/m2 carboplatin, complete remission of the brain metastases occurred. A pharmacokinetic study during the second course revealed low levels of carboplatin in the cerebrospinal fluid.Keywords
This publication has 11 references indexed in Scilit:
- Current status of chemotherapy for ovarian carcinomaEuropean Journal of Cancer and Clinical Oncology, 1988
- Comparative distribution and excretion of carboplatin and cisplatin in miceCancer Chemotherapy and Pharmacology, 1988
- Central nervous system metastases in epithelial ovarian carcinomaCancer, 1987
- Optimizing drug delivery to brain tumorsCancer Treatment Reviews, 1987
- High-dose carboplatin in refractory ovarian cancer patients.Journal of Clinical Oncology, 1987
- CENTRAL-NERVOUS-SYSTEM METASTASES IN EPITHELIAL OVARIAN-CARCINOMA1986
- Preclinical studies identifying carboplatin as a viable cisplatin alternativeCancer Treatment Reviews, 1985
- COMPARATIVE ACTIVITY AND DISTRIBUTION STUDIES OF 5 PLATINUM ANALOGS IN NUDE-MICE BEARING HUMAN OVARIAN-CARCINOMA XENOGRAFTS1985
- Treatment of advanced ovarian cancer with cisplatin, adriamycin, and cyclophosphamide: Effect of treatment and incidence of intracranial metastasesJournal of Surgical Oncology, 1983
- Analysis of platinum in biological materials by flameless atomic absorption spectrophotometryBiochemical Medicine, 1977